228 related articles for article (PubMed ID: 16436353)
1. Sclerodermatous chronic graft-versus-host disease presenting with dysphagia.
Tamagawa R; Takenaka H; Katoh N; Shimazaki C; Bamba H; Kishimoto S
Eur J Dermatol; 2006; 16(1):92-3. PubMed ID: 16436353
[No Abstract] [Full Text] [Related]
2. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
Tolland JP; Devereux C; Jones FC; Bingham EA
Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic challenge. Sclerodermoid graft-versus-host disease (GVHD) with lichensclerosus-like lesions.
Kung EF; Soltani K; Petronic-Rosic V
Int J Dermatol; 2008 Jul; 47(7):655-7. PubMed ID: 18613868
[No Abstract] [Full Text] [Related]
4. A case of severe sclerodermatous chronic graft-versus-host disease: exposure to cement containing abundant silica may have been a relevant factor in scleroderma-like skin changes.
Uenishi T; Sugiura H
J Dermatol; 2005 May; 32(5):413-5. PubMed ID: 16043910
[No Abstract] [Full Text] [Related]
5. Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease.
Kim JB; Liakopoulou E; Watson JS
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1235-8. PubMed ID: 17509955
[TBL] [Abstract][Full Text] [Related]
6. Sclerodermatous changes of chronic graft-versus-host-disease treated with puva.
Woscoff A; Ruíz Lascano A; De Pablo AB; Robinson A
Int J Dermatol; 1996 Sep; 35(9):656-8. PubMed ID: 8876297
[No Abstract] [Full Text] [Related]
7. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
8. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
9. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation.
Nakamura K; Kawakami Y; Oyama N; Kaneko F; Abe H; Sagara H; Ohto H
J Dermatol; 2006 Feb; 33(2):135-8. PubMed ID: 16556284
[TBL] [Abstract][Full Text] [Related]
10. Stool smears for diagnosis of intestinal acute graft-versus-host disease.
Hirano K; Kondo F; Kondo Y; Kurosawa K; Suwabe S; Noguchi Y; Miura N; Kakuda H; Sato T; Niimi H
Bone Marrow Transplant; 1999 Oct; 24(7):799-801. PubMed ID: 10516685
[TBL] [Abstract][Full Text] [Related]
11. [The skin manifestations of the graft vs. host reaction].
Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
[TBL] [Abstract][Full Text] [Related]
12. Neuropathy in chronic graft-versus-host disease caused by donor T cells.
Haruki H; Koga M; Ogasawara J; Omoto M; Kawai M; Kanda T
Muscle Nerve; 2012 Oct; 46(4):610-1. PubMed ID: 22987708
[No Abstract] [Full Text] [Related]
13. Generalized vitiligo after allogeneic bone marrow transplantation.
Cho SB; Roh MR; Chung KY; Lee KH; Park YK
Acta Derm Venereol; 2005; 85(1):82-3. PubMed ID: 15849005
[No Abstract] [Full Text] [Related]
14. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.
Voltarelli JC; Ahmed H; Paton EJ; Stracieri AB; Holman P; Bashey A; Coutinho M; Simoes BP; Ball ED; Carrier E
Bone Marrow Transplant; 2001 Jul; 28(1):97-9. PubMed ID: 11498752
[TBL] [Abstract][Full Text] [Related]
15. A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation.
Cereda M; Trocino G; Pogliani EM; Schiavina R
Ital Heart J; 2003 Jan; 4(1):60-3. PubMed ID: 12690924
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
[TBL] [Abstract][Full Text] [Related]
17. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
[No Abstract] [Full Text] [Related]
18. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
Ziemer M; Thiele JJ; Gruhn B; Elsner P
J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
[No Abstract] [Full Text] [Related]
19. Pustular acral erythema in a patient with acute graft-versus-host disease.
Ruiz-Genao DP; GF-Villalta MJ; Peñas PF; Fraga J; García-Díez A; Fernández-Herrera J
J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):550-3. PubMed ID: 12941091
[TBL] [Abstract][Full Text] [Related]
20. Koebnerizing sclerodermatous graft-versus-host disease caused by donor lymphocyte infusion and interferon-alpha.
White JM; Devereux S; Pagliuca A; Salisbury JR; du Vivier AW; Creamer D
Br J Dermatol; 2006 Sep; 155(3):621-3. PubMed ID: 16911292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
